1JL.MU
Price
Unusual options activity
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
5 more panels on 1JL.MU open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 20 | MALLARD LAWRENCE B Chief Financial Officer |
STOCK | 1 | $0 | Direct |
| Jul 1, 20 | ZHANG PEIFANG Director |
STOCK | 12.66K | $0 | Direct |
| Apr 9, 20 | WISNIEWSKI DAVID M. Officer |
— | 1.89K | — | Direct |
| Apr 1, 20 | NEELY WILSON S. Director |
STOCK | 17.86K | $0 | Direct |
| Feb 21, 20 | GASTON ROGER C Officer |
— | 4.14K | — | Direct |
| Feb 21, 20 | LIFSEY WALTER T Chief Operating Officer |
— | 10.37K | — | Direct |
| Feb 21, 20 | GAWRONSKI GRANT L Officer |
— | 10.34K | — | Direct |
| Feb 21, 20 | JUREK IVO Chief Executive Officer |
— | 30.07K | — | Direct |
| Feb 21, 20 | SEELY JAMEY S General Counsel |
— | 4.40K | — | Direct |
| Feb 21, 20 | WISNIEWSKI DAVID M. Officer |
— | 1.94K | — | Direct |
| Feb 21, 20 | IRELAND JAMES W Director |
STOCK | 9.92K | $0 | Direct |
| Feb 21, 20 | KLEBE TERRY A. Director |
STOCK | 9.92K | $0 | Direct |
| Feb 21, 20 | MAINS STEPHANIE K. Director |
STOCK | 9.92K | $0 | Direct |
| Dec 4, 19 | GAWRONSKI GRANT L Officer |
— | 25.43K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
GASTON ROGER C |
Officer | 16.59K | Conversion of Exercise of derivative security |
GAWRONSKI GRANT L |
Officer | 70.78K | Conversion of Exercise of derivative security |
IRELAND JAMES W |
Director | 22.45K | Stock Award(Grant) |
JUREK IVO |
Chief Executive Officer | 200.46K | Conversion of Exercise of derivative security |
LIFSEY WALTER T |
Chief Operating Officer | 83.44K | Conversion of Exercise of derivative security |
MALLARD LAWRENCE B |
Chief Financial Officer | 1 | Stock Award(Grant) |
NEELY WILSON S. |
Director | 17.86K | Stock Award(Grant) |
SEELY JAMEY S |
General Counsel | 5.88K | Conversion of Exercise of derivative security |
WISNIEWSKI DAVID M. |
Officer | 3.97K | Conversion of Exercise of derivative security |
ZHANG PEIFANG |
Director | 12.66K | Stock Award(Grant) |
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.44B | $3.41B | $3.57B | $3.55B | +1.0% |
| Operating revenue | $3.44B | $3.41B | $3.57B | $3.55B | +1.0% |
| Cost of revenue | $2.07B | $2.05B | $2.21B | $2.30B | +1.1% |
| Gross profit | $1.37B | $1.36B | $1.36B | $1.25B | +1.0% |
| Selling, general & admin | $876.10M | $876.50M | $884.70M | $853.70M | -0.0% |
| Total operating expense | $876.10M | $876.50M | $884.90M | $853.90M | -0.0% |
| Operating income | $495.60M | $482.00M | $474.00M | $396.70M | +2.8% |
| Net interest income | -$123.60M | -$125.80M | -$163.20M | -$139.40M | +1.7% |
| Pre-tax income | $340.20M | $328.00M | $285.30M | $257.80M | +3.7% |
| Tax provision | $63.10M | $107.50M | $28.30M | $14.90M | -41.3% |
| Net income | $251.40M | $194.90M | $232.90M | $220.80M | +29.0% |
| Net income to common | $251.40M | $194.90M | $232.90M | $220.80M | +29.0% |
| EBIT | $458.40M | $460.70M | $448.50M | $397.20M | -0.5% |
| EBITDA | $672.20M | $677.60M | $666.00M | $614.40M | -0.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $812.10M | $682.00M | $720.60M | $578.40M | +19.1% |
| Cash & short-term investments | $812.10M | $682.00M | $720.60M | $578.40M | +19.1% |
| Accounts receivable | $744.20M | $722.70M | $768.20M | $808.60M | +3.0% |
| Inventory | $700.00M | $676.00M | $647.20M | $656.20M | +3.6% |
| Total current assets | $2.48B | $2.31B | $2.40B | $2.28B | +7.6% |
| Property, plant & equipment | $746.10M | $718.90M | $750.10M | $769.70M | +3.8% |
| Goodwill & intangibles | $3.23B | $3.16B | $3.42B | $3.47B | +2.2% |
| Total assets | $7.15B | $6.79B | $7.25B | $7.19B | +5.4% |
| Total current liabilities | $735.40M | $721.50M | $779.30M | $752.30M | +1.9% |
| Current debt | $36.20M | $39.10M | $36.50M | $36.60M | -7.4% |
| Long-term debt | $2.20B | $2.31B | $2.42B | $2.43B | -5.0% |
| Total debt | $2.36B | $2.48B | $2.56B | $2.58B | -4.9% |
| Total liabilities | $3.46B | $3.45B | $3.71B | $3.75B | +0.5% |
| Retained earnings | $1.65B | $1.48B | $1.46B | $1.48B | +11.7% |
| Shareholder equity | $3.33B | $3.02B | $3.22B | $3.11B | +10.3% |
| Working capital | $1.75B | $1.58B | $1.62B | $1.53B | +10.2% |
| Net tangible assets | $106.40M | -$133.90M | -$204.60M | -$361.50M | +179.5% |
| Shares issued | 253.54M | 255.20M | 264.26M | 282.58M | -0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $276.30M | $219.90M | $256.40M | $242.50M | +25.6% |
| Depreciation & amortisation | $213.80M | $216.90M | $217.50M | $217.20M | -1.4% |
| Stock-based compensation | $27.20M | $28.80M | $27.40M | $44.30M | -5.6% |
| Change in working capital | $21.30M | -$26.00M | $74.70M | -$157.50M | +181.9% |
| Operating cash flow | $478.10M | $379.60M | $481.00M | $265.80M | +25.9% |
| Capital expenditure | -$113.90M | -$106.70M | -$71.40M | -$87.00M | -6.7% |
| Investing cash flow | -$119.00M | -$104.40M | -$81.80M | -$90.70M | -14.0% |
| Share buybacks | -$119.30M | -$176.10M | -$251.70M | -$175.90M | +32.3% |
| Financing cash flow | -$251.10M | -$286.70M | -$258.30M | -$253.10M | +12.4% |
| Free cash flow | $364.20M | $272.90M | $409.60M | $178.80M | +33.5% |
| End cash position | $815.00M | $684.80M | $724.00M | $581.40M | +19.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $941.60M | $851.10M | $856.20M | $855.70M | $883.70M | +10.6% |
| Operating revenue | $941.60M | $851.10M | $856.20M | $855.70M | $883.70M | +10.6% |
| Cost of revenue | $555.50M | $513.10M | $530.90M | $514.10M | $523.50M | +8.3% |
| Gross profit | $386.10M | $338.00M | $325.30M | $341.60M | $360.20M | +14.2% |
| Selling, general & admin | $250.70M | $226.90M | $209.50M | $219.20M | $231.20M | +10.5% |
| Total operating expense | $250.70M | $226.90M | $209.50M | $219.20M | $231.20M | +10.5% |
| Operating income | $135.40M | $111.10M | $115.80M | $122.40M | $129.00M | +21.9% |
| Net interest income | -$28.50M | -$27.70M | -$37.20M | -$32.80M | -$33.10M | -2.9% |
| Pre-tax income | $100.20M | $77.90M | $71.40M | $94.80M | $80.20M | +28.6% |
| Tax provision | -$78.00M | $11.50M | $15.00M | $6.10M | $16.80M | -778.3% |
| Net income | $170.90M | $59.70M | $51.30M | $81.60M | $56.50M | +186.3% |
| Net income to common | $170.90M | $59.70M | $51.30M | $81.60M | $56.50M | +186.3% |
| EBIT | $128.70M | $106.30M | $103.70M | $125.50M | $107.30M | +21.1% |
| EBITDA | $185.80M | $162.00M | $158.40M | $179.10M | $160.60M | +14.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $823.50M | $785.30M | $812.10M | $689.40M | $719.70M | +4.9% |
| Cash & short-term investments | $823.50M | $785.30M | $812.10M | $689.40M | $719.70M | +4.9% |
| Accounts receivable | $900.30M | $799.60M | $744.20M | $833.30M | $826.30M | +12.6% |
| Inventory | $740.60M | $685.70M | $700.00M | $718.10M | $729.00M | +8.0% |
| Total current assets | $2.71B | $2.49B | $2.48B | $2.48B | $2.52B | +8.8% |
| Property, plant & equipment | $745.60M | $751.50M | $746.10M | $751.30M | $751.60M | -0.8% |
| Goodwill & intangibles | $3.15B | $3.18B | $3.23B | $3.23B | $3.25B | -1.1% |
| Total assets | $7.39B | $7.12B | $7.15B | $7.15B | $7.22B | +3.9% |
| Total current liabilities | $835.10M | $678.50M | $735.40M | $705.40M | $729.30M | +23.1% |
| Current debt | $39.20M | $30.90M | $36.20M | $30.50M | $39.80M | +26.9% |
| Long-term debt | $2.19B | $2.20B | $2.20B | $2.20B | $2.30B | -0.2% |
| Total debt | $2.36B | $2.36B | $2.36B | $2.36B | $2.47B | -0.1% |
| Total liabilities | $3.50B | $3.39B | $3.46B | $3.43B | $3.61B | +3.3% |
| Retained earnings | $1.81B | $1.67B | $1.65B | $1.67B | $1.59B | +7.9% |
| Shareholder equity | $3.52B | $3.37B | $3.33B | $3.37B | $3.27B | +4.6% |
| Working capital | $1.87B | $1.81B | $1.75B | $1.78B | $1.79B | +3.5% |
| Net tangible assets | $376.60M | $187.60M | $106.40M | $143.20M | $14.00M | +100.7% |
| Shares issued | 253.15M | 253.86M | 253.54M | 258.25M | 257.45M | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $178.00M | $66.20M | $56.30M | $88.60M | $63.10M | +168.9% |
| Depreciation & amortisation | $57.10M | $55.70M | $54.70M | $53.60M | $53.30M | +2.5% |
| Stock-based compensation | $9.40M | $6.30M | $4.80M | $6.70M | $9.60M | +49.2% |
| Change in working capital | -$57.80M | -$80.40M | $180.90M | -$38.70M | -$12.70M | +28.1% |
| Operating cash flow | $78.60M | $30.20M | $269.80M | $98.00M | $103.00M | +160.3% |
| Capital expenditure | -$18.70M | -$21.50M | -$33.50M | -$24.80M | -$29.40M | +13.0% |
| Investing cash flow | -$14.60M | -$27.20M | -$32.10M | -$24.90M | -$31.00M | +46.3% |
| Share buybacks | -$22.10M | -$16.60M | -$106.30M | $0 | $0 | -33.1% |
| Financing cash flow | -$25.70M | -$25.10M | -$116.20M | -$101.50M | -$8.80M | -2.4% |
| Free cash flow | $59.90M | $8.70M | $236.30M | $73.20M | $73.60M | +588.5% |
| End cash position | $826.50M | $788.20M | $815.00M | $692.30M | $722.80M | +4.9% |
Options analytics
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 5, 26 | UBS | MAINTAINED | Buy | Buy |
| Dec 16, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Nov 14, 25 | Wells Fargo | INITIATED | — | Equal-Weight |
| Nov 6, 25 | UBS | MAINTAINED | Buy | Buy |
| Oct 30, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Oct 30, 25 | Citigroup | MAINTAINED | Buy | Buy |
| Oct 30, 25 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 25, 25 | JP Morgan | INITIATED | — | Overweight |
| Aug 4, 25 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 31, 25 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 31, 25 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jul 31, 25 | UBS | MAINTAINED | Buy | Buy |
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.